The last ten years have seen a notable increase in balloon pulmonary angioplasty safety.

Published Date: 23 Apr 2023

The treatment of chronic thromboembolic pulmonary hypertension with balloon pulmonary angioplasty has an evolving safety profile over the years, from 2013 to 2022, as revealed by an analysis of more than two dozen studies.

Read Full News

Latest News

Australia Confirms First H5N1 Bird Flu Case in Local Mammal

Australia on Sunday confirmed its first case of H5N1 bird flu in a mammal, with the deadly virus ⁠found in a long-nosed fur seal in South Australia state.

Nerandomilast Lowers Mortality Risk in Pulmonary Fibrosis

Nerandomilast is associated with reduced mortality risk in patients with pulmonary fibrosis, a pooled analysis of two trials shows.

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

New GLP-1 Concern; FDA Sued by Health Groups; Over 750 Dead in Ebola Outbreak

Health news and commentary gathered by MedPage Today staff

Todays Updates

Faster 1-Hour MI Rule-Out Is Safe

The 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.

Edoxaban Falls Short After Intracranial Hemorrhage in AF

Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.

Drug Benefit Seen in Nonobstructive HCM

A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.

Tailored Approach Shortens Endocarditis Therapy

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

Todays Updates

Faster 1-Hour MI Rule-Out Is Safe

The 1-hour troponin pathway was safely implemented in a real-world study but did not impact workflow in busy emergency departments.

Edoxaban Falls Short After Intracranial Hemorrhage in AF

Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.

Drug Benefit Seen in Nonobstructive HCM

A multicenter phase 3 trial has associated a cardiac myosin inhibitor with meaningful clinical benefit in nonobstructive HCM, for which there has been no effective therapies.

Tailored Approach Shortens Endocarditis Therapy

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

Latest News

Australia on Sunday confirmed its first case of H5N1 bird flu in a mammal, with the deadly virus ⁠found in a long-nosed fur seal in South Australia state.

Nerandomilast is associated with reduced mortality risk in patients with pulmonary fibrosis, a pooled analysis of two trials shows.

Mastering the HER2 Spectrum for Individualized Management of Advanced/Metastatic NSCLC

Expert Insights on the Next Wave of IO Combinations in mNSCLC

Treating Advanced Disease With Bispecific ADCs: Mechanisms of Action and Therapeutic Rationale for Bispecific ADCs in Solid Tumors

Health news and commentary gathered by MedPage Today staff

News All Time

Real-World Study Backs Mepolizumab in Rhinosinusitis With Nasal Polyps

— 20% of patients were on their way to remission

Tenax Heart Drug Fails to Improve Walking Results in Study, Shares Plunge

Tenax Therapeutics said on Monday its experimental drug did not significantly improve how far patients could walk compared with ⁠placebo in a late-stage trial for a...

Overheard in Medicine: Pandemic Wounds Reopened

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

Ivacaftor Boosts Height and Lung Function in Cystic Fibrosis

Children and young adults with cystic fibrosis, especially those with severe CFTR variants, who receive ivacaftor have improved height and lung capacity than peers who do not receive ivacaftor.

Housing Aid Linked to Better NSCLC Survival

Housing assistance was associated with lower mortality among older adults with NSCLC, but the survival advantage was not explained by differences in guideline-concordant treatment.

More Bronchiectasis Patients Benefit From HEMT

Data from the US Bronchiectasis and NTM Research Registry show improvements in cough and exacerbations with highly effective modulator therapy.

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Case Report: Paradoxical Bronchoconstriction with Short-Acting Beta Agonist

Clinicians perform pulmonary function tests to find the cause

Why Is a Fit Swimmer Breathless and Coughing Up Blood?

Case highlights a little-known, potentially dangerous, often recurrent condition of swimmers

Psychosis and Cannabis Legalization: Where's the Evidence?

As marijuana policy shifts nationwide, researchers are tracking possible link to psychosis

FDA Staff Blindsided by Move Allowing More E-Cigs, Nicotine Pouches Onto Market

It's highly unusual for the FDA to draft new policies without input from the staffers

Chronic Sinus Inflammation Linked to Roadway Gases

Gaseous pollutants from traffic sources add to evidence for particulate-matter harms

Targeted Lung Cancer Drug Aces Confirmatory Trial in Frontline Setting

Upfront treatment options set to expand for NSCLC patients with EGFR exon 20 insertions

Drug Combo for Lung Cancer Beats Pembrolizumab in First-Line Trial

Antibody-drug conjugate plus pembrolizumab superior to pembrolizumab alone in PD-L1 expressors

Upfront Ivonescimab Plus Chemo Bests PD-1 Inhibitor Combo in Advanced NSCLC

HARMONi-6 showed 34% drop in death risk, but trial had an all-Asian population, expert warned

'Immediately Practice-Changing' Lung Cancer Trial in Curative Setting

Substantial EFS improvement with selpercatinib in RET fusion-positive disease

Recommended News For You

Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma

Shorter but More Intense RT: A Better Option for HNSCC?

Are patients with advanced cancer receiving treatment aligned with their goals?

Benefits of perioperative radiotherapy for liver cancer with a high risk of recurrence are investigated in research.

Inner Thoughts of Leonard Bernstein, the "Maestro".

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

Breast cancer screening in women's 40s can save lives, study says

Recommended Articles For You

Anion Gap: The Simple Calculation That Reveals Much About Your Health  

MMA Embolization in Chronic Subdural Hematoma: Evidence, Outcomes, and Gaps 

Emerging Therapies Using Synthetic Hematopoietic Support Systems 

Nipple-Sparing Mastectomy: Oncologic Safety and Patient Selection Review 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Adjuvant Tx May Boost Survival in Bilateral Breast Cancer

2.

Lower screening age calls for more tailored bowel cancer surveillance

3.

Study identifies new approach to protect the brain during radiation therapy

4.

Research exposes far-reaching toll of financial hardship on patients with cancer

5.

Q&A: Breast cancer facts that could save lives

1.

Revolutionizing Cancer Care: The Impact of Darzalex Faspro

2.

Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment

3.

Clinical Pharmacology of Erythropoiesis-Stimulating Pathway Modulators

4.

Exploring New Treatment Strategies for Mantle Cell Lymphoma

5.

Managing High Potassium Levels: A Comprehensive Guide to Veltassa 

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Understanding the causes of anemia in adults beyond nutritional deficiencies

2.

Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia

3.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

4.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot